Literature DB >> 508506

Effect of the antihistamines, brompheniramine maleate and triprolidine hydrochloride, on performance in man.

A N Nicholson.   

Abstract

1 Effects of brompheniramine maleate (4 and 12 mg) and triprolidine hydrochloride (2.5 and 10 mg) on visuo-motor coordination, and on subjective assessments of performance, well-being and sleep were each studied in six subjects at 0.5, 1.5, 3.0, 5.0 and 7.0 h after ingestion. The doses refer to immediate and sustained release preparations respectively. 2. Triprolidine hydrochloride (2.5 mg) had an immediate effect on performance which persisted to 3.0 h, and the sustained release preparation (10 mg) impaired performance from 1.5 to 5.0 h. Brompheniramine maleate (4 mg) impaired performance from 1.5 to 3.0 h, and the sustained release preparation (12 mg) impaired performance at 1.5 h. There were no consistent changes in the subjective assessments of performance, or of well-being and sleep. 3. The studies emphasize the variable effects of antihistamines on performance, and suggest that effects on performance of sustained release preparations may be similar to those of the usual form. Sustained release preparations may provide an advantage in clinical practice if the antihistaminic activity is prolonged.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508506      PMCID: PMC1429839          DOI: 10.1111/j.1365-2125.1979.tb04712.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Performance studies with antihistamines.

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  Some clinical pharmacological studies with terfenadine, a new antihistamine drug.

Authors:  V K Kulshrestha; P P Gupta; P Turner; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

3.  Promethazine on hand-eye co-ordination and visual function.

Authors:  A T Large; G Wayte; P Turner
Journal:  J Pharm Pharmacol       Date:  1971-02       Impact factor: 3.765

4.  Some central and peripheral effects of meclastine, a new antihistaminic drug, in man.

Authors:  A Hedges; W P Maclay; A J Newman-Taylor; P Turner
Journal:  J Clin Pharmacol New Drugs       Date:  1971 Mar-Apr

5.  The evaluation of histamine antagonists in man.

Authors:  A S Fowle; D T Hughes; G J Knight
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

6.  Evidence for tolerance to the central nervous effects of the histamine antagonist, triprolidine, in man.

Authors:  C E Bye; R Claridge; A W Peck; F Plowman
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

7.  A comparison of triprolidine and clemastine on histamine antagonism and performance tests in man: implications for the mechanism of drug induced drowsiness.

Authors:  A W Peck; A S Fowle; C Bye
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

8.  Effect of promethazine hydrochloride on hand-eye co-ordination.

Authors:  G R Molson; J A Mackey; J V Smart; P Turner
Journal:  Nature       Date:  1966-01-29       Impact factor: 49.962

  8 in total
  15 in total

1.  Effects of a sedative and of a non-sedative H1-antihistamine on the event-related potential (ERP) in normal volunteers.

Authors:  F M Swire; C A Marsden; C Barber; A T Birmingham
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Antihistamines: impaired performance and the tendency to sleep.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Is the crew fit to fly? II: Specific medical considerations.

Authors:  R M Harding; F J Mills
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-16

4.  Treatment of seasonal and perennial rhinitis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-26

5.  The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers.

Authors:  J S Kerr; C Dunmore; I Hindmarch
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

6.  Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine.

Authors:  A N Nicholson; B M Stone
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

7.  Single and repeated dose comparison of three antihistamines and phenylpropanolamine: psychomotor performance and subjective appraisals of sleep.

Authors:  T Seppälä; E Nuotto; K Korttila
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

8.  Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.

Authors:  K A Brookhuis; G De Vries; D De Waard
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

9.  The H1-antagonist mequitazine: studies on performance and visual function.

Authors:  A N Nicholson; B M Stone
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  Behavioural effects of histamine and its antagonists: a review.

Authors:  J M White; G R Rumbold
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.